NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1487035242 M.D.
Verify on CMS → Sherwin Desouza, M.D.
Hematology & Oncology Physician in Indianapolis, Indiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,215 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
101
Medicare Part D claims · 30 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
48%
generic claims · 52% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
79.5/100
▼ 4 pts below national avg 83.1 · Above neutral
Industry payments
$5.9K
28 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Sherwin Desouza, M.D. reported a CMS MIPS final score of 79.5/100 - below the 83.1 national average - and filed 101 Medicare Part D claims in 2023.
- 79.5/100
- MIPS score · -4 vs avg
- 101
- Part D claims, 2023
- 48%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Sherwin Desouza, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
80 30th percentile higher than 30% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Sherwin Desouza, M.D. sits
This provider among hematology & oncology physician peers
Across the 4,233 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Sherwin Desouza, M.D. writes more Part D claims than 9% of them and scores higher on MIPS quality than 30% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Sherwin Desouza, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Sherwin Desouza, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 4 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Sherwin Desouza, M.D.?
Near national averagePrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
101 88% vs specialty avg
MIPS final score
79.5/100 3.6 pts vs avg
Specialty distribution in Indiana
How Hematology & Oncology Physician compares to other specialties among Indiana providers
Medicare quality performance, MIPS
Sherwin Desouza, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 79.5/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Hematology & Oncology Physician) - 79.5/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Sherwin Desouza, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 8326 NAAB RD, Indianapolis, IN, 46260, with a listed phone of (317) 871-0011. NPI 1487035242 was issued on 06/17/2015.
Medicare Part D records for calendar year 2023 show 101 prescription claims written by this provider, covering 30 Medicare beneficiaries and totaling roughly $370K in drug spend, split 52% brand-name and 48% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 79.5/100 for the 2023 performance year (Quality 68.5, Cost 63.1), compared with the national average of 83.1.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1487035242 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/17/2015 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
79.4829
Final Score
Avg: 83.1
68.5144
Quality
63.0952
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Sherwin Desouza, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, Sherwin Desouza, M.D. is affiliated with 4 Medicare-billing facilities across 2 states.
Indiana Hemophilia And Thrombosis Center, Inc.
Indianapolis, IN
Innovative Hematology Inc
Indianapolis, IN
IU Health Medical Group LLC
Indianapolis, IN
University Hospitals Medical Group Inc
Cleveland, OH
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Sherwin Desouza, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$5.9K
Largest payer
GENZYME CORPORATION
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Sherwin Desouza, M.D. - brand share 52.0%
Hematology & Oncology Physician average
52% brand-name claims vs 48% generic, on 101 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
101
Total Claims
$370K
Total Drug Cost
30
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 163
- Total Day Supply
- 4,572
- Brand vs Generic
- 52% brand / 48% generic
- Brand Drug Cost
- $365K
- Generic Drug Cost
- $4K
Patient Demographics
- Average Patient Age
- 78.5 years
- Avg HCC Risk Score
- 2.42
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 0, 65-74: N/A, 75-84: 13, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Eliquis Apixaban | 40 |
| Hydroxyurea | 21 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Sherwin Desouza, M.D. fits within the Hematology & Oncology Physician landscape nationally.
11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Sherwin Desouza, M.D.'s 101 claims are below the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in Indiana
Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as Desouza.
Dr. Mohammad Abu Zaid
M.D.
Kokomo, IN
Dr. Farrukh Adhami
MD
Fort Wayne, IN
Dr. Nabil Adra
MD
Indianapolis, IN
Dr. Lakshmi Aggarwal
MD
Fort Wayne, IN
Dr. Maqbool Ahmed
M.D.
Evansville, IN
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Indiana medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Indiana
Frequently Asked Questions
What is Sherwin Desouza, M.D.'s specialty? ▼
Sherwin Desouza, M.D. specializes in Hematology & Oncology Physician and practices in Indianapolis, Indiana. Credentials: M.D..
How much does Sherwin Desouza, M.D. prescribe under Medicare Part D? ▼
In 2023, Sherwin Desouza, M.D. wrote 101 Medicare Part D claims totaling $370K in drug costs for 30 beneficiaries.
What is Sherwin Desouza, M.D.'s Medicare quality score? ▼
Sherwin Desouza, M.D. has a CMS MIPS Final Score of 79.5/100 (Quality: 68.5, Cost: 63.1). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Sherwin Desouza, M.D. located? ▼
Sherwin Desouza, M.D. is located at 8326 NAAB RD, Indianapolis, IN, 46260. Phone: (317) 871-0011.
What is Sherwin Desouza, M.D.'s NPI number? ▼
Sherwin Desouza, M.D.'s National Provider Identifier (NPI) is 1487035242, issued on 06/17/2015.
Does Sherwin Desouza, M.D. prescribe more brand-name or generic drugs? ▼
Sherwin Desouza, M.D.'s prescribing is 52% brand-name and 48% generic drugs by claim count, with $365K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Sherwin Desouza, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Sherwin Desouza, M.D.'s most frequently prescribed drugs include Eliquis, Hydroxyurea. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Sherwin Desouza, M.D. accept Medicare? ▼
Sherwin Desouza, M.D. appears in CMS Medicare data with 101 Part D claims and 30 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Sherwin Desouza, M.D.'s credentials? ▼
Sherwin Desouza, M.D.'s NPI is 1487035242 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.